185 related articles for article (PubMed ID: 25300222)
1. The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism.
Minarikova Z; Gaspar L; Kruzliak P; Celecová Z; Oravec S
Lipids Health Dis; 2014 Oct; 13():158. PubMed ID: 25300222
[TBL] [Abstract][Full Text] [Related]
2. [Elevated Lipoprotein(a) Cncentration and Presence of Subfractions of Small Dense Low Density Lipoproteins as Independent Factors of Risk of Ischemic Heart Disease].
Afanasieva OI; Utkina EA; Artemieva NV; Ezhov MV; Adamova IY; Pokrovsky SN
Kardiologiia; 2016 Jun; 56(6):5-11. PubMed ID: 28290840
[TBL] [Abstract][Full Text] [Related]
3. Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels.
Hayashi T; Koba S; Ito Y; Hirano T
Lipids Health Dis; 2017 Jan; 16(1):21. PubMed ID: 28125987
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes.
Viktorinova A; Malickova D; Svitekova K; Choudhury S; Krizko M
Diabetes Res Clin Pract; 2021 Jun; 176():108858. PubMed ID: 34015391
[TBL] [Abstract][Full Text] [Related]
5. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
[TBL] [Abstract][Full Text] [Related]
6. The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in patients with dyslipoproteinemia and comparison with plasma atherogenicity indicators--A pilot study.
Kucera M; Balaz D; Kruzliak P; Ciccocioppo R; Oravec S; Rodrigo L; Zulli A; Hirnerova E; Sabaka P; Komornikova A; Sabo J; Slezak P; Gaspar L
Clin Biochem; 2015 Jun; 48(9):557-61. PubMed ID: 25727667
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
[TBL] [Abstract][Full Text] [Related]
8. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
9. Decrease in LDL size in HIV-positive adults before and after lopinavir/ritonavir-containing regimen: an index of atherogenicity?
Badiou S; Merle De Boever C; Dupuy AM; Baillat V; Cristol JP; Reynes J
Atherosclerosis; 2003 May; 168(1):107-13. PubMed ID: 12732393
[TBL] [Abstract][Full Text] [Related]
10. Small-dense low-density lipoproteins are the predominant apoB-100-containing lipoproteins in cord blood.
Gugliucci A; Numaguchi M; Caccavello R; Kimura S
Clin Biochem; 2014 Apr; 47(6):475-7. PubMed ID: 24362269
[TBL] [Abstract][Full Text] [Related]
11. Small, dense LDL cholesterol and apolipoprotein B: relationship with serum lipids and LDL size.
Vekic J; Zeljkovic A; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Bogavac-Stanojevic N; Memon L; Spasic S
Atherosclerosis; 2009 Dec; 207(2):496-501. PubMed ID: 19632678
[TBL] [Abstract][Full Text] [Related]
12. Thyroid function influences serum apolipoprotein B-48 levels in patients with thyroid disease.
Mugii S; Hanada H; Okubo M; Masuda D; Takeoka K; Hidaka Y; Ohama T; Matsuyama A; Nakagawa-Toyama Y; Nishida M; Ishigami M; Komuro I; Yamashita S
J Atheroscler Thromb; 2012; 19(10):890-6. PubMed ID: 22786447
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
14. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a direct enzymatic assay and polyacrylamide tube gel electrophoresis for measurement of small, dense low-density lipoprotein cholesterol.
Vanavanan S; Srisawasdi P; Rochanawutanon M; Kerdmongkol J; Kroll MH
Clin Chem Lab Med; 2015 Jan; 53(1):139-48. PubMed ID: 25153396
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
17. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive assessment of lipoprotein subfraction profiles according to glucose metabolism status, and association with insulin resistance in subjects with early-stage impaired glucose metabolism.
Lee JE; Min SH; Lee DH; Oh TJ; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
Int J Cardiol; 2016 Dec; 225():327-331. PubMed ID: 27756036
[TBL] [Abstract][Full Text] [Related]
19. Associations between the levels of thyroid hormones and lipid/lipoprotein levels: Data from National Health and Nutrition Examination Survey 2007-2012.
Jain RB
Environ Toxicol Pharmacol; 2017 Jul; 53():133-144. PubMed ID: 28549315
[TBL] [Abstract][Full Text] [Related]
20. Effect of atorvastatin on low-density lipoprotein subpopulations and comparison between indicators of plasma atherogenicity: a pilot study.
Kucera M; Oravec S; Hirnerova E; Huckova N; Celecova Z; Gaspar L; Banach M
Angiology; 2014 Oct; 65(9):794-9. PubMed ID: 24163116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
